News & Updates

Waist-height ratio predicts severe diabetic eye disease risk in T1D
Waist-height ratio predicts severe diabetic eye disease risk in T1D
08 Feb 2022 byStephen Padilla

Waist-height ratio (WHtR), a hallmark of central obesity, appears to be a good indicator for the risk of developing severe diabetic eye disease (SDED) in adults with type 1 diabetes (T1D), results of a 15-year cohort study suggest.

Waist-height ratio predicts severe diabetic eye disease risk in T1D
08 Feb 2022
Systemic inflammation mediates obesity-related severe COVID-19
Systemic inflammation mediates obesity-related severe COVID-19
04 Feb 2022 byStephen Padilla

Systemic inflammation plays a significant role in severe COVID-19 associated with obesity, particularly in patients aged <65 years, as captured by peak C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR), a study has found.

Systemic inflammation mediates obesity-related severe COVID-19
04 Feb 2022
Tirzepatide regulates metabolites, lipids in T2D
Tirzepatide regulates metabolites, lipids in T2D
02 Feb 2022

Treatment with tirzepatide leads to a reduction in body weight and improvement in glycaemic control in individuals with type 2 diabetes (T2D), reports a study. In addition, it modulates metabolites associated with T2D risk and metabolic dysregulation that is consistent with improved metabolic health.

Tirzepatide regulates metabolites, lipids in T2D
02 Feb 2022
Waist circumference, not BMI, a good indicator of outcomes in older diabetics
Waist circumference, not BMI, a good indicator of outcomes in older diabetics
02 Feb 2022

In older patients with type 2 diabetes (T2D), use of body mass index (BMI) does not adequately predict clinical outcomes associated with obesity, but waist circumference (WC) appears to be up to the task.

Waist circumference, not BMI, a good indicator of outcomes in older diabetics
02 Feb 2022